Related references
Note: Only part of the references are listed.Therapeutic outcome of diphencyprone and its correlation with serum cytokine profile in alopecia areata
Rakhavi P. Manimaran et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
SERUM LEVELS OF IL-2 AND IL-17A ARE RELATED TO CLINICAL TYPE AND SEVERITY OF ALOPECIA AREATA
Mohammad Azhar Aljabali et al.
Wiadomosci Lekarskie (2022)
Genetic Association between Interleukin Genes and Alopecia Areata in Jordanian Patients
Laith N. AL-Eitan et al.
Oman Medical Journal (2022)
TNF-α Affects Signature Cytokines of Th1 and Th17 T Cell Subsets through Differential Actions on TNFR1 and TNFR2
Barbara Pesce et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Increased serum levels of interleukin-17 in patients with alopecia areata and non-segmental vitiligo
Katarzyna A. Tomaszewska et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2022)
Diphenylcyclopropenone plays an effective therapeutic role by up-regulating the TSLP/OX40L/IL-13 pathway in severe alopecia areata
Yugang Gong et al.
EXPERIMENTAL DERMATOLOGY (2021)
Alopecia Areata New Treatment Options Including Janus Kinase Inhibitors
Caiwei Zheng et al.
DERMATOLOGIC CLINICS (2021)
IFN-α and TNF-α serum levels and their association with disease severity in Egyptian children and adults with alopecia areata
Shaimaa I. Omar et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2021)
The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
Anna Waskiel-Burnat et al.
CELLS (2021)
Blockade of IL-7 signaling suppresses inflammatory responses and reverses alopecia areata in C3H/HeJ mice
Zhenpeng Dai et al.
SCIENCE ADVANCES (2021)
Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
Ozge Askin et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2021)
Serum level of IL-4 predicts response to topical immunotherapy with diphenylcyclopropenone in alopecia areata
Yugang Gong et al.
EXPERIMENTAL DERMATOLOGY (2020)
The profile of cytokines (IL-2, IFN-γ, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata
Ram Kishan Gautam et al.
JOURNAL OF COSMETIC DERMATOLOGY (2020)
IL12B and IL23R polymorphisms are associated with alopecia areata
Pardis-Sadat Tabatabaei-Panah et al.
GENES AND IMMUNITY (2020)
Increased Serum Levels of IFN-γ, IL-1β, and IL-6 in Patients with Alopecia Areata and Nonsegmental Vitiligo
Katarzyna Tomaszewska et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2020)
Development of alopecia in patients treated with interleukin-17 inhibitors
Layal Antoury et al.
DERMATOLOGIC THERAPY (2020)
IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
Luana S. Ortolan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Response to ustekinumab in three pediatric patients with alopecia areata
Abdullah Aleisa et al.
PEDIATRIC DERMATOLOGY (2019)
Serum concentrations of selected proinflammatory cytokines in children with alopecia areata
Katarzyna Tabara et al.
POSTEPY DERMATOLOGII I ALERGOLOGII (2019)
IL-17 inhibition: is it the long-awaited savior for alopecia areata?
Yuval Ramot et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2018)
The Balance of Th17 versus Treg Cells in Autoimmunity
Gap Ryol Lee
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
Teresa Song et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)
Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients
S. -H. Loh et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Correlation between serum IL-17A level and SALT score in patients with alopecia areata before and after NB-UVB therapy
Hanan Morsy et al.
JOURNAL OF COSMETIC DERMATOLOGY (2018)
Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata
Emma Guttman-Yassky et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2018)
Th1/Th2 PB balance and CD200 expression of patients with active severe alopecia areata
Xinhua Ma et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases
Kunal Malik et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2017)
T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-) in patients with alopecia areata: association with clinical type and severity
Mona A. Atwa et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2016)
Serum cytokine and chemokine profiles in patients with alopecia areata
O. Bilgic et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2016)
B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of Alopecia Areata
Mostafa A. Elela et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2016)
The many faces of interleukin-17 in inflammatory skin diseases
R. Speeckaert et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism
Emma Guttman-Yassky et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Molecular signatures define alopecia areata subtypes and transcriptional biomarkers
Ali Jabbari et al.
EBIOMEDICINE (2016)
Altered expression of intracellular Toll-like receptors in peripheral blood mononuclear cells from patients with alopecia areata
Abdullateef A. Alzolibani et al.
BBA CLINICAL (2016)
Polymorphisms in the promoter regions of the CXCL1 and CXCL2 genes contribute to increased risk of alopecia areata in the Korean population
S. K. Kim et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions
Dhavalkumar D. Patel et al.
IMMUNITY (2015)
Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
Mayte Suarez-Farinas et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
The genetics of alopecia areata: New approaches, new findings, new treatments
Roni Biran et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2015)
Imbalance of T-helper 17 and regulatory T cells in patients with alopecia areata
Yu-Mei Han et al.
JOURNAL OF DERMATOLOGY (2015)
Investigation of interleukin-12, interleukin-17 and interleukin-23 receptor gene polymorphisms in alopecia areata
Nesrin Aytekin et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2015)
PTPN22 profile indicates a novel risk group in Alopecia areata
Dhaval G. Bhanusali et al.
HUMAN IMMUNOLOGY (2014)
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Luzhou Xing et al.
NATURE MEDICINE (2014)
T-helper and regulatory T-cell cytokines in the peripheral blood of patients with active alopecia areata
M. K. Tembhre et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population
Goknur Kalkan et al.
GENE (2013)
Genome-wide expression analysis suggests unique disease-promoting and disease-preventing signatures in Pemphigus vulgaris
R. Dey-Rao et al.
GENES AND IMMUNITY (2013)
Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata
Lina M. Forstbauer et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2012)
Alopecia areata as a model for T cell-dependent autoimmune diseases
Marta Bertolini et al.
EXPERIMENTAL DERMATOLOGY (2012)
Calcitonin gene-related peptide (CGRP) may award relative protection from interferon-?-induced collapse of human hair follicle immune privilege
Michael Kinori et al.
EXPERIMENTAL DERMATOLOGY (2012)
Safety and Efficacy of Adalimumab for the Treatment of Severe Alopecia Areata: Case Series of Three Patients
Chantal Bolduc et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2012)
A Mouse Model of Clonal CD8+ T Lymphocyte-Mediated Alopecia Areata Progressing to Alopecia Universalis
Rajshekhar Alli et al.
JOURNAL OF IMMUNOLOGY (2012)
Follow-Up Study of the First Genome-Wide Association Scan in Alopecia Areata: IL13 and KIAA0350 as Susceptibility Loci Supported with Genome-Wide Significance
Dagny Jagielska et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2012)
New Interleukin-23 Pathway Inhibitors in Dermatology Ustekinumab, Briakinumab, and Secukinumab
Marta Kurzeja et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2011)
Platelet-Activating Factor Induces Th17 Cell Differentiation
Anne-Marie Drolet et al.
MEDIATORS OF INFLAMMATION (2011)
Tumor necrosis factor-alpha in patients with alopecia areata
Emina Kasumagic-Halilovic et al.
INDIAN JOURNAL OF DERMATOLOGY (2011)
Serum Cytokine Levels and Anxiety and Depression Rates in Patients with Alopecia Areata
Arzu Ataseven et al.
EURASIAN JOURNAL OF MEDICINE (2011)
Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy
N. Barahmani et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2010)
Essential and synergistic roles of IL1 and IL6 in human Th17 differentiation directed by TLR ligand-activated dendritic cells
Risa K. Benwell et al.
CLINICAL IMMUNOLOGY (2010)
Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity
A. B. Coda et al.
GENES AND IMMUNITY (2010)
Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures
Raghunandan Dudda Subramanya et al.
GENOMICS (2010)
Genome-wide association study in alopecia areata implicates both innate and adaptive immunity
Lynn Petukhova et al.
NATURE (2010)
Cytokines and Other Mediators in Alopecia Areata
Stamatis Gregoriou et al.
MEDIATORS OF INFLAMMATION (2010)
Worsening alopecia areata and de novo occurrence of multiple halo nevi in a patient receiving infliximab
C. Fabre et al.
DERMATOLOGY (2008)
Induction of IL-17+ T cell trafficking and development by IFN-γ:: Mechanism and pathological relevance in psoriasis
Ilona Kryczek et al.
JOURNAL OF IMMUNOLOGY (2008)
Cutting Edge: IFN-γ Enables APC to Promote Memory Th17 and Abate Th1 Cell Development
Ilona Kryczek et al.
JOURNAL OF IMMUNOLOGY (2008)
TNF-α drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses
Sanju Iwamoto et al.
JOURNAL OF IMMUNOLOGY (2007)
TH-17 cells in the circle of immunity and autoimmunity
Estelle Bettelli et al.
NATURE IMMUNOLOGY (2007)
A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage
Lawrence Steinman
NATURE MEDICINE (2007)
Signals mediated by transforming growth factor-β initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease
Marc Veldhoen et al.
NATURE IMMUNOLOGY (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis
Y Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Alopecia areata: A tissue specific autoimmune disease of the hair follicle
A Gilhar et al.
AUTOIMMUNITY REVIEWS (2006)
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions
CA Hunter
NATURE REVIEWS IMMUNOLOGY (2005)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Share Paper
